Psychometrics of patient-reported bother from side effects of treatment single-items in industry-sponsored oncology trials

被引：0
|
作者：
Peter C. Trask
Tracy Holt
Timothy Pearman
机构：
[1] Genentech,
[2] PAREXEL International,undefined
[3] Supportive Oncology,undefined
[4] Robert H. Lurie Comprehensive Cancer Center of Northwestern University,undefined
[5] School of Medicine,undefined
来源：
Quality of Life Research | 2023年 / 32卷
关键词：
Quality of life; Oncology; Single item measure; Symptom bother; Clinical trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2601 / 2615
页数：14
相关论文
共 50 条
  • [21] Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis
    Strand, V
    Cohen, S
    Crawford, B
    Smolen, JS
    Scott, DL
    RHEUMATOLOGY, 2004, 43 (05) : 640 - 647
  • [22] Development of a Patient-Reported Outcome Measure of Neurological Side Effects from Immunosuppression in Kidney Transplant Recipients.
    Hurt, C.
    Greene, G. J.
    Friedewald, J.
    Ladner, D. P.
    Waterman, A.
    Cella, D.
    Peipert, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 939 - 940
  • [23] RECOMMENDATIONS FOR THE COLLECTION OF PATIENT-REPORTED OUTCOMES (PRO) DATA IN THE POST-PROGRESSION AND POST-TREATMENT SETTING FOLLOWING ONCOLOGY CLINICAL TRIALS
    Oladapo, O.
    D'Alessio, D.
    Vallow, S.
    VALUE IN HEALTH, 2021, 24 : S61 - S61
  • [24] PATIENT-REPORTED SIDE EFFECTS OF BUPRENORPHINE-NALOXONE: IDENTIFYING INDEPENDENT PREDICTORS FROM PATIENT VIEWS AND CLINICAL ASSESSMENT DURING MAINTENANCE TREATMENT OF HEROIN USE DISORDER
    Perez de los Cobos, J.
    Alcaraz, S.
    Trujols, J.
    Sinol, N.
    Vergara-Moragues, E.
    Gonzalez-Saiz, F.
    VALUE IN HEALTH, 2018, 21 : S276 - S276
  • [25] Solifenacin treatment for overactive bladder in Hispanic patients:: patient-reported symptom bother and quality of life outcomes from the VESIcare® Open-Label Trial
    Capo, J. P., Jr.
    Laramee, C.
    Lucente, V.
    Fakhoury, A.
    Forero-Schwanhaeuser, S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (01) : 39 - 46
  • [26] Nivolumab related side effects based on patient-reported outcomes: A multicenter study from real-life setting
    Karadas, Canan
    Metin, Zehra Gok
    Izgu, Nur
    Porucu, Canan
    Karadurmus, Nuri
    Kilickap, Sadettin
    Demirci, Umut
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [27] Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30
    N. Lynn Henry
    Sungjin Kim
    Ron D. Hays
    Marcio A. Diniz
    Mourad Tighiouart
    Gillian Gresham
    Michael Luu
    Reena S. Cecchini
    Greg Yothers
    André Rogatko
    Patricia A. Ganz
    npj Breast Cancer, 8
  • [28] Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30
    Henry, N. Lynn
    Kim, Sungjin
    Hays, Ron D.
    Diniz, Marcio A.
    Tighiouart, Mourad
    Gresham, Gillian
    Luu, Michael
    Cecchini, Reena S.
    Yothers, Greg
    Rogatko, Andre
    Ganz, Patricia A.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [29] REAL-WORLD MULTIPLE MYELOMA PATIENT EXPERIENCE BY FRAILTY STATUS: SYMPTOM BURDEN, PHYSICAL FUNCTION, QUALITY OF LIFE, AND TREATMENT BOTHER CAPTURED FROM ELECTRONIC PATIENT-REPORTED OUTCOMES (EPROS)
    Coombs, N.
    Beamon, E.
    Rusli, E.
    Wujcik, D.
    Galaznik, A.
    Jamy, O.
    VALUE IN HEALTH, 2024, 27 (06) : S323 - S323
  • [30] Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial
    Vardy, M. D.
    Mitcheson, H. D.
    Samuels, T. -A.
    Wegenke, J. D.
    Forero-Schwanhaeuser, S.
    Marshall, T. S.
    He, W.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (12) : 1702 - 1714
12345